Oracle (NYSE:ORCL) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.18 by 2.54 percent. This is unchanged from the same period last year. The company reported quarterly
BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW)))) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce the
Forza X1 Inc (NASDAQ: FRZA) shares are trading lower by 41% on a week-to-date basis after the company on Monday announced an $8 million public offering.